Athenex, Inc. Announces Second Quarter 2019 Financial Results, Positive Phase III Results on Oral Paclitaxel plus Encequidar and Increased Product Sales Guidance

August 7, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search